eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all . Please read our guidelines before submitting your own eLetter.
Research ArticleCANCER
TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis
- View ORCID ProfileWojciech Rosikiewicz1,2,*,†,
- View ORCID ProfileXiaowen Chen1,*,
- View ORCID ProfilePilar M. Dominguez3,*,‡,
- View ORCID ProfileHussein Ghamlouch4,
- View ORCID ProfileSaid Aoufouchi5,
- Olivier A. Bernard4,
- View ORCID ProfileAri Melnick3,§ and
- View ORCID ProfileSheng Li1,6,7,8,§
- 1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
- 2Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN, USA.
- 3Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
- 4INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
- 5CNRS UMR8200, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
- 6The Jackson Laboratory Cancer Center, Bar Harbor, ME, USA.
- 7Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, CT, USA.
- 8Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, USA.
- ↵§Corresponding author. Email: amm2014{at}med.cornell.edu (A.M.); sheng.li{at}jax.org (S.L.)
↵* These authors contributed equally to this work.
↵† Present address: Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN, USA.
↵‡ Present address: Cancer Research Division, Peter MacCallum Cancer Centre, and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
See allHide authors and affiliations
Science Advances 17 Jun 2020:
Vol. 6, no. 25, eaay5872
DOI: 10.1126/sciadv.aay5872
Vol. 6, no. 25, eaay5872
DOI: 10.1126/sciadv.aay5872
Wojciech Rosikiewicz
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
2Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN, USA.
Xiaowen Chen
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Pilar M. Dominguez
3Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
Hussein Ghamlouch
4INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Said Aoufouchi
5CNRS UMR8200, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Olivier A. Bernard
4INSERM U1170, équipe labelisée Ligue Nationale Contre le Cancer, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Ari Melnick
3Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
Sheng Li
1The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
6The Jackson Laboratory Cancer Center, Bar Harbor, ME, USA.
7Department of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, CT, USA.
8Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, USA.
Submit a Response to This Article
No eLetters have been published for this article.